...Executive Summary Background Sunpharma, as a pharmaceutical company, is going to modify its business model to base revenue on customer satisfactory. -Strengths & Opportunities -Threats & Weakness 1. Wider products assortment 1. Shortage of competent pharmacists 2. Good relationship with business partners 2. Fierce competition 3. Corporation cultural focus on people 3. Pharmacist lack of “soft skills” 4. Self-service design 5. Upcoming favorable legislation HR challenges and recommendations After fully understand the current environment, HR faces external challenges such as constrained workforce, fierce competition and unfavorable current law. Conditions within the organizations are insufficient budget, uncooperative pharmacists and invalid customer service management. Aligning the environment, HR implements the firm’s strategy and develops policies and practices to support the company change, including the improvement of performance appraisal and payroll system, development of the learning organization, enhancement of the employee relations and partnership with universities. Implementation plan -Hire professionals from outside to held seminars and online resources: The seminar will include communication, sales, and interpersonal skills. We will separate...
Words: 403 - Pages: 2
...tablets and capsules, and when taken with or without food. These differences could result in a change in tolerability and control of symptoms. To discontinue Tizanidine Hydrochloride, decrease dose slowly to minimize the risk of withdrawal and rebound hypertension, tachycardia, and hypertonia. 1.5.4 Dosage forms and strengths Capsules: 2 mg, 4 mg or 6 mg thrice per day Tablets 4 mg three times per day 1.5.5 Drawbacks of the currently available formulation Sedation Increases liver enzymes(upto 5%); therefore Liver function test need to be followed High dose and dosing frequency(as per its potency) ie., 3 times daily for chronic use Low bioavailability due to extensive first pass metabolism by CYP1A2 Expensive(Tizan tablets by sunpharma costs Rs102 per 10 tablets) 1.6 ORAL DRUG DELIVERY It is the most preferred and convenient option as the oral route provides maximum active surface area among all drug delivery system for administration of various drugs. Amongst them Gastroretentive drug delivery is an approach to prolong gastric residence time, thereby targeting site-specific drug release in the upper gastrointestinal tract (GIT) for local or systemic effects. Gastroretentive dosage forms can remain in the gastric region for long periods and hence significantly prolong the gastric retention time (GRT) of drugs.Also to add to its beneficiary activity Gastroretentive Osmotic pumps are one of the systems for controlled drug delivery. Osmotic drug delivery systems typically...
Words: 1572 - Pages: 7
...Financial Management II PROJECT REPORT Submitted To: Submitted By: Prof. Chhavi Mehta Section B (Group No. – 9) Aashish Pant (15PGDM066) Akshita Jain(15PGDM070) Neelima Jain(15PGDM096) Nupur Goyal (15PGDM098) Siddharth Warrier (15PGDM119) Pharmaceuticals Industry in India: Overview: Indian pharmaceutical sector accounts for about 2.4 per cent of the global pharmaceutical industry in value terms and 10 per cent in volume terms and is expected to expand at a Compound Annual Growth Rate (CAGR) of 15.92 per cent to US$ 55 billion by 2020 from US$ 20 billion in 2015. With 71 per cent market share, generic drugs form the largest segment of the Indian pharmaceutical sector. By 2016, India is expected to be the third-largest global generic Active Pharmaceutical Ingredient (API) merchant market. The country accounts for the second largest number of Abbreviated New Drug Applications (ANDAs) and is the world’s leader in Drug Master Files (DMFs) applications with the US. Indian drugs are exported to more than 200 countries in the world, with the US as the key market. Generic drugs account for 20 per cent of global exports in terms of volume, making the country the largest provider of generic medicines globally and expected to expand even further in coming years. Pharmaceuticals Exports Promotion Council (Pharmexcil) expects pharmaceutical exports to reach US$ 25 billion in 2015. The Government...
Words: 1727 - Pages: 7
...Research Journal of Finance and Accounting www.iiste.org ISSN 2222-1697 (Paper) ISSN 2222-2847 (Online) Vol.6, No.3, 2015 27 Predicting Stock Market using Regression Technique Prof. Mitesh A. Shah1* Dr.C.D.Bhavsar2 1.Department of Statistics, S.V. Vanijya Mahavidyalaya, Ahmedabad, Gujarat, India 2.Department of Statistics, Gujarat University, Ahmedabad, Gujarat, India Email of the corresponding Author: m_a_shah73@yahoo.com Abstract We use two and half year data set of 50 companies of Nifty along with Nifty from 1st Jan 2009 to 28th June 2011 and apply multivariate technique for data reduction, namely Factor Analysis. Using Factor analysis we reduce these 50 companies’ data (50 variables) into the most significant 4 FACTORS. These four significant factors are then used to predict the Nifty using Multiple linear regression. We observed that the model is good fitted and it explained 90 % of the total variance. Keywords: Nifty, Factor Analysis, Multiple Linear Regression, Data reduction 1. Introduction: In this paper, we applying data reduction technique of Factor analysis on the Nifty Stocksand then predict NIFTY using Multiple Linear Regression Technique. Factor analysis is a statistical technique to study interrelationship among the Variables. The idea behind factor analysis is grouping the variables by their correlation in such a way that particular group is highly correlated among themselves but relatively smaller correlation with the variables in other group...
Words: 3557 - Pages: 15
...News analysis since 20th April 2013 The Economist • Speed isn’t everything For years critics of china have complained that it prizes over balance. Rapid development has taken it as the heavy investment has crowded out consumption & heavy industry has muscled out services. According to the new figures the loss of momentum & spectacular surge in the credit made the stock market unhappy. In short China is becoming more like a western economy with consumer & services to the fore that reinforce each other. Services are more labor intensive than industries are, their growth boosts wages & household income, fatter pay-packages, encourage consumption & consumer spending that favors services. “Results become cause & cause become results” This has made a huge contribution to China’s growth. The tightness in the labor market shows that China is operating close to its limits. Rather than chasing growth govt. has made shadow-banking regulation stricter, preserved with curbs on property speculation. The Economic Times 25th April 2013 • RBI strikes gold with its yellow metal stock It has earned 41% returns from gold reserves since 2009, 4 times more than other assets. • RBI may prod private bank to enforce KYC norms May push banks to rationalize commissions paid to their wealth & relationship managers in order to discourage dubious transactions. • Create more banks. Chit funds will die. Lack of financial inclusion. • Economists isn’t as smart as dentistry • When entrepreneurs...
Words: 1555 - Pages: 7
...Strategy Formulation & Implementation Ranbaxy Laboratories Ltd 1. Summary: Indian pharmaceutical industry is estimated at $8 billion in 2013 and had been growing at an average rate of 8–9 %. The industry was highly fragmented with more than 1000 players out of which 30% of market was controlled by top ten companies and the rest of 70% by small companies. The Global pharmaceutical industry was estimated at $ 600 billion in 2013. Indian pharmaceutical industry has become more innovative and enterprising with more investment in R&D especially since the WTO agreement was signed. Indian drug makers command 10 per cent share in the USD 30 billion US generic drug market and also has the highest (over 150) US Foods & Drug Administration (FDA) approved facilities. US accounts for one-fourth of the Indian drug exports. The share of Indian pharma companies in the total approvals for generic drugs called Abbreviated New Drug Application (ANDA) has risen steadily. From 32 per cent in 2009, it went up to 38.5 per cent in 2013. Increasing share of Indian companies in total ANDAs approved by the USFDA can be attributed to increase spending by them for research and development (R&D) activities. As per CMIE’s database, the industry’s R&D expenses to sales ratio jumped to around five per cent in 2012-13 from around three per cent in 2003-04. The export of drugs from India is expected to grow by 4.2 per cent to USD 15.2 billion in 2013-14. Around USD 16.3 billion of drugs are likely to be...
Words: 11886 - Pages: 48
...at work Annual Report 2009-10 Contents Management Discussion and Analysis ............................. 01 Directors’ Report ....................... 26 Historical Performance .............. 29 Key Performance Indicators ....... 30 Corporate Information .............. 32 Auditors’ Report ........................ 36 Balance Sheet ............................ 40 Profit and Loss Account ............. 41 Cash Flow Statement ................. 42 Statement Relating to Subsidiary Companies ................ 71 Corporate Governance ............... 72 Auditors’ Report - Consolidated ........................... 83 Consolidated Balance Sheet ....... 84 Consolidated Profit and Loss Account ...................... 85 Consolidated Cash Flow Statement ................. 86 At work The cover depicts an artist’s representation of a gyroscope. Encyclopedia Britannica says the 19th C French physicist Foucault gave the name gyroscope to a wheel or rotor mounted in gimbal rings. Such a spinning wheel maintained its original orientation in space regardless of the Earth’s rotation, which made it ideal as a direction indicator. Gyroscopes are used in compasses and automatic pilots on ships and aircraft, in the steering mechanisms of torpedoes, and in the inertial guidance systems installed in space launch vehicles, ballistic missiles, and orbiting satellites. The steadfastness of the gyroscope is quite like the philosophy we work by at Sun Pharma. Staying the course, steady and consistent, despite...
Words: 41744 - Pages: 167
...Prelude The Union Budget for 2012-13 (FY13) is to be presented in the Parliament on 16th March. As every year, the budget will be an event that would signal the direction set forth for the growth path of the economy. Global as well as the domestic investors would also be looking for signals. The attempt of the government to push for higher growth without sound economic fundamentals has further resulted in higher inflation, increased current account deficit, tighter inter-bank liquidity, and sub-optimal utilization of the tax payers’ money. The major expectations that surround the budget can be summarized as below: Sustainability in curbing government expenditure to check on the imbalances created by the fiscal deficit, without curbing consumption; Managing current account deficits and trade imbalances; Direction to catapult private investment, gross capital formation; Managing supply side constraints; and Empowering the under privileged with skills and knowledge for self-sustenance. A revival in investment cycle should be the way forward for the economy to drive a revival in productivity, rather than depending on consumption to drive productivity. Further, the supply side constraints, if exist for a prolonged period, would cripple the economy and the government would require greater fiscal and monetary...
Words: 7509 - Pages: 31
...NATURAL PROGRESSION Annual Report 2010-11 Acme Plaza, Andheri - Kurla Rd, Andheri (E), Mumbai - 400 059. Tel : 91-22-66969696 Fax: 91-22-28212010 www.sunpharma.com Final - Resize Sun pharma Cover.indd 1 13/08/2011 8:13:09 PM CONTENTS Natural Progression Lines depicting steps—incremental 02 Key Performance Indicators 03 Ten Year Financial Highlights change, gradual growth, lines sloping 04 Management Discussion and Analysis upwards. Innumerable such steps adding 22 Directors’ Report up, to form a smooth growth pattern when seen from a distance. Progress shown with 25 Annexure to Directors’ Report lines racing to the distance, to infinity. The 28 Auditors’ Report cover shows an artist’s interpretation of the company’s progress 32 Balance Sheet 33 Profit and Loss Account 34 Cash Flow Statement 69 Corporate Governance 83 Auditors’ Report Consolidated 84 Consolidated Balance Sheet 85 Consolidated Profit and Loss Account 86 Consolidated Cash Flow Statement 111 Statement Relating to Subsidiary ompanies Corporate Information Inside Back Cover Disclaimer Statements in this Management Discussion and Analysis describing the Company s objectives, projections, estimates, expectations, plans or predictions or industry conditions or events may be forward looking statements within the meaning of applicable securities laws andregulations. Actual results, performance or achievements could differ materially from those expressed...
Words: 45525 - Pages: 183
